GM&a;C Life Sciences Fund is a provider of venture capital funds to entrepreneurs operating in the life sciences area.
Business Model: B2B
Revenue: $10.4M
Employees: 11-50
Address: Alderley Park, Alderley Edge
City: Cheshire
State: england
Zip: SK10 4TG
Country: GB
The GM&a;C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire &a; Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures"). The Fund is based at Alderley Park, which is well recognised as a site of national importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&a;D headquarters for AstraZeneca. Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
9/2018 | Biorelate | Venture Round | 0 |
3/2018 | Renephra | Seed Round | 327.5k |
11/2020 | Flynotes | Venture Round | - |
9/2018 | Biorelate | Seed Round | 921.7k |
9/2016 | SwabTech | Seed Round | 752k |
1/2018 | Acea Health | Seed Round | - |
3/2018 | Maxwellia | Seed Round | 992.4k |
1/2016 | Kanichi Research Services | Venture Round | - |
5/2016 | Blueberry Therapeutics | Venture Round | 4.3M |
9/2017 | Elucid mHealth | Series A | 1.9M |
2/2018 | Manchester Imaging | Seed Round | 856k |
10/2018 | Clin-e-cal | Venture Round | - |
12/2019 | Pencil Biosciences | Seed Round | 673.7k |
3/2016 | Biorelate | Seed Round | 141.7k |
11/2017 | metaLinear | Seed Round | 339.3k |
8/2018 | Nexus Labs (Surgical Teaching) | Seed Round | - |
4/2018 | CLYZ Labs | Seed Round | - |
7/2020 | CroBio | Seed Round | - |
6/2017 | Cytox | Series B | 3.4M |
10/2017 | Gendius | Series A | - |
3/2019 | AMR Centre | Angel Round | 3M |
1/2016 | Pronec | Seed Round | 73.7k |
1/2017 | Tectores | Seed Round | - |
9/2016 | ViroStatics | Seed Round | - |
1/2016 | Arlabion | Seed Round | - |
4/2017 | Proveca | Venture Round | 5M |
1/2018 | SurgaColl | Series A | 0 |
1/2016 | Backpain Help | Seed Round | - |
6/2021 | QV Bioelectronics | Seed Round | 0 |
9/2020 | Panthera Biopartners | Series A | - |
1/2017 | AMR Centre | Venture Round | - |
10/2016 | Apex Molecular | Venture Round | - |
6/2021 | QV Bioelectronics | Seed Round | 0 |
11/2020 | Flynotes | Venture Round | - |
9/2020 | Panthera Biopartners | Series A | - |
7/2020 | CroBio | Seed Round | - |
12/2019 | Pencil Biosciences | Seed Round | 0 |
3/2019 | AMR Centre | Angel Round | 0 |
10/2018 | Clin-e-cal | Venture Round | - |
9/2018 | Biorelate | Venture Round | 0 |
8/2018 | Nexus Labs (Surgical Teaching) | Seed Round | - |
4/2018 | CLYZ Labs | Seed Round | - |
Name | Price |
---|
Name | Size | Announced Date |
---|